ET
GILD icon

Equitable Trust’s Gilead Sciences GILD Stock Holding History

Equitable Trust’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.99M Buy
50,177
+714
+1% +$100K 0.32% 63
2025
Q4 		$6.07M Buy
49,463
+32,310
+188% +$3.93M 0.27% 70
2025
Q3 		$1.9M Hold
17,153
– – 0.09% 157
2025
Q2 		$1.9M Sell
17,153
-292
-2% -$31.1K 0.09% 157
2025
Q1 		$1.95M Buy
17,445
+265
+2% +$27.3K 0.11% 155
2024
Q4 		$1.59M Sell
17,180
-424
-2% -$38.2K 0.09% 164
2024
Q3 		$1.48M Hold
17,604
– – 0.09% 161
2024
Q2 		$1.21M Buy
17,604
+1,029
+6% +$68.7K 0.08% 169
2024
Q1 		$1.21M Sell
16,575
-2,494
-13% -$192K 0.08% 173
2023
Q4 		$1.54M Sell
19,069
-483
-2% -$37.6K 0.12% 140
2023
Q3 		$1.47M Buy
19,552
+1,255
+7% +$96.5K 0.12% 138
2023
Q2 		$1.41M Buy
18,297
+484
+3% +$38.6K 0.11% 144
2023
Q1 		$1.48M Sell
17,813
-771
-4% -$63.9K 0.12% 142
2022
Q4 		$1.6M Buy
+18,584
New +$1.47M 0.13% 144
2021
Q3 		– Sell
-3,446
Closed -$237K – 367
2021
Q2 		$237K Buy
+3,446
New +$230K 0.02% 333

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Equitable Trust's GILD Position: Q1 2026 in Review

Equitable Trust increased its Gilead Sciences (GILD) stake by 1.4% in Q1 2026, buying an estimated $100K and bringing the position to 50,177 shares worth $6.99M. The position accounts for 0.32% of the portfolio, ranked #63.

Equitable Trust first reported a position in GILD in Q2 2021 and has held it in 15 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Equitable Trust held 50,177 shares of Gilead Sciences worth $6.99M as of Q1 2026.
  • Equitable Trust bought 714 Gilead Sciences shares in Q1 2026, an estimated $100K.
  • Gilead Sciences made up 0.32% of Equitable Trust's portfolio in Q1 2026, its #63 holding.
  • Equitable Trust first reported a position in Gilead Sciences in Q2 2021 and has held it in 15 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Equitable Trust's 13F filing for Q1 2026, filed 30 Apr 2026.